THE WOODLANDS, Texas--(BUSINESS WIRE)--Repros Therapeutics Inc. (NasdaqGM:RPRX) announced today that the Company’s Senior Vice President of Medical and Regulatory Affairs, Andre van As MD PhD, will make a presentation at a Special Symposium of the 13th World Congress of Gynecological Endocrinology, in Florence, Italy, February 28-March 2, 2008. The title of the oral presentation will be The Safety and Efficacy of Proellex® (CBD4124) in the Management of Symptomatic Uterine Fibroids and Endometriosis. His talk will be part of a Symposium entitled “Effects of Progesterone Receptor Modulators in Female Reproductive Health with Emphasis on the Endometrium” and will take place on February 28. Dr. van As will make one of four presentations on the effects of progesterone receptor modulators in the female reproductive tract. George Mutter MD, Associate Professor of Pathology, Brigham and Women’s Hospital, Harvard Medical School of Boston will make a presentation entitled, Proellex® effects on the endometrium; Alistair Williams MD, Department of Pathology, Royal Infirmary of Edinburgh, Scotland will speak on Patterns of endometrial morphology with progesterone receptor modulators; and Philippe Bouchard, MD, Professor and Chair, Service d’Endocrinologie, Hospital Saint Antoine, Paris, will address Effects of Ulipristal (CDB 2914, VA 2914) in women. The Special Symposium will be co-chaired by Irving M. Spitz, MD, DSc, Professor of Medicine, Weill Medical College of Cornell University and Ben Gurion University of the Negev, Institute of Hormone Research, Jerusalem, and Regine Sitruk-Ware, MD, Adjunct Professor, Rockefeller University and Executive Director Research and Development, Center for Biomedical Research, Population Council, New York City.
